Home » Topics » Conferences

Conferences
RSS

Phase III European trial results reinforce potential value of anti-LFA-1 MAb

Feb. 17, 1998

CellCept evaluated in the clinic for another new indication

Feb. 17, 1998

More data on HMR's malononitrilamides presented at scientific congress

Feb. 16, 1998

SDZ-RAD: a novel immunosuppressant progresses in the Novartis pipeline

Feb. 13, 1998

Lilly describes second-generation NK1 antagonist

Feb. 11, 1998

New implant for delivery of LHRH agonists

Feb. 11, 1998

MMAS results discussed at world congress

Feb. 10, 1998

Clinical results of LHRH antagonist in BPH and prostate cancer

Feb. 10, 1998

Pernasal testosterone: a novel administration route for androgenic substitution

Feb. 9, 1998

Sustiva-containing combinations highly effective in reducing viral load in HIV-infected patients

Feb. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...